COVID-19 vaccine sprint as Pfizer-BioNTech, Moderna seek emergency EU approval
Pfizer Inc and BioNTech have applied to the European drugs regulator for conditional authorization of their COVID-19 vaccine, following similar steps in the United States and Britain, the companies said on Tuesday. Ciara Lee reports.
UP NEXT
UP NEXT
-
Vaccine shortages arise across U.S., halting inoculations in some places
Reuters
-
Fast-spreading UK coronavirus variant could be dominant in U.S. by March, CDC says
Reuters
-
Exclusive: International COVID-19 vaccine poll shows higher mistrust of Russia, China shots
Reuters
-
Retired doctors and more syringes: Biden lays out plan to get America vaccinated
Reuters
-
WHO team arrives in China's Wuhan to investigate COVID-19 origins
Reuters
-
COVID-19 infection gives some immunity, but virus can still be spread, study finds
Reuters
-
Second year of pandemic 'could even be tougher': WHO's Ryan
Reuters
-
Indonesia launches vaccination drive as COVID-19 deaths hit record
Reuters
-
China sees growing COVID-19 threat as more cities locked down
Reuters
-
U.S. to require negative COVID-19 tests for arriving international air passengers
Reuters
-
EU wraps preliminary talks to buy 60 million Valneva COVID vaccines
Reuters
-
Gorillas at San Diego Zoo Safari Park diagnosed with COVID-19
Reuters
-
Two gorillas at San Diego Zoo test positive for COVID-19
Reuters
-
BioNTech lifts 2021 COVID-19 vaccine output target to 2 billion doses
Reuters
-
UK steps up vaccinations as COVID surges, worst weeks still to come
Reuters
-
Britain approves Moderna's COVID-19 vaccine, eyes spring rollout
Reuters